Please provide your email address to receive an email when new articles are posted on . Researchers compared the 21-valent vaccine to a combination of a 15-valent and 23-valent vaccines. Fewer adverse ...

-- Company to host a live webcast event with an expert panel of clinicians during ASH -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of ...

The U.S. Personal Consumption Expenditures (PCE) Price Index, the Federal Reserve’s preferred inflation gauge, was released on Dec. 5. It remains one of the most closely watched indicators across ...

Shares in Valneva VLA-0.32%decrease; red down pointing triangle rose after the French biotech company reported positive final data from a mid-stage study of a Lyme disease vaccine candidate it is ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

The latest announcement is out from PDS Biotechnology ( (PDSB)). On November 10, 2025, PDS Biotechnology Corporation announced positive clinical and translational data at the 2025 Society for ...

The last time I wrote about Immuneering Corporation (IMRX), it was in a Seeking Alpha article entitled "Immuneering: Phase 1 Data Release IMM-1-104 Leads To Additional 2024 Milestone." With respect to ...

(RTTNews) - REGENXBIO Inc. (RGNX) announced positive data from the Phase I/II/III CAMPSIITE trial of clemidsogene lanparvovec or RGX-121 for the treatment of patients with Mucopolysaccharidosis Type ...

Positive topline results from two phase 3 trials reported this week may expand the treatment landscape for generalized myasthenia gravis (gMG), a rare autoimmune disease marked by debilitating muscle ...

In a prior column, I highlighted the life and work of Yvon Chouinard, the founder of Patagonia, who gave away that multi-billion-dollar company to organizations working on the environment, including ...